Prosecution Insights
Last updated: November 20, 2026

Ruth A Davis, USPTO Patent Examiner

Listed by the USPTO as DAVIS, RUTH A

Tech Center 1600 • Art Units: 1645 1651 1653 1699

This examiner grants 61% of resolved cases

Analysis

DAVIS, RUTH A is assigned to Tech Center 1600 and Art Unit 1645. Her record includes 921 resolved cases, with an allowance rate of 61.0%. The median time to allowance is 1168 days, and interview lift is 30.9%, indicating a positive association between interviews and allowance outcomes.

The leading companies are DSM IP Assets B.V., Ipsen Biopharm Limited, and Genmont Biotech Incorporation. The leading firms are Casimir Jones, S.C., NIXON & VANDERHYE, PC, and PROSKAUER ROSE LLP. The profile supports preparing technically focused interview agendas while maintaining detailed written claim analysis. The allowance rate and median timeline suggest that applications may require substantive prosecution over an extended period before resolution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

61.0%
Allow Rate
+1.0% vs TC avg
970
Total Applications
+30.9%
Interview Lift
1168
Avg Prosecution Days
Based on 921 resolved cases, 2023–2026

Rejection Statute Breakdown

3.8%
§101 Eligibility
15.6%
§102 Novelty
36.6%
§103 Obviousness
27.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18885857 MANUFACTURING METHOD OF MIXED POWDER, MIXED POWDER, POWDER, AND POWDER MEDIUM Non-Final OA FUJIFILM Corporation
18952409 STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS Non-Final OA TAKEDA PHARMACEUTICAL COMPANY LIMITED
18840767 USES OF BIFIDOBACTERIUM LONGUM MICROORGANISMS HAVING THE CAPACITY TO DEGRADE BOTH HMO AND PLANT-DERIVED GLYCANS Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18096899 TREATMENT OF MODERATE TO VERY SEVERE GLABELLAR LINES AND LATERAL CANTHAL LINES Final Rejection Ipsen Biopharm Limited
17759674 TREATMENT OF SKIN CONDITIONS Non-Final OA IPSEN BIOPHARM LIMITED
18872675 COMBINATIONS COMPRISING VITAMIN C AND LACTOBACILLUS RHAMNOSUS Non-Final OA DSM IP Assets B.V.
18834722 YARROWIA PRODUCTION PROCESS Non-Final OA DSM IP ASSETS B.V.
18775012 ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS Non-Final OA Northwestern University
18867205 MICROORGANISM BELONGING TO GENUS AKKERMANSIA Non-Final OA OTSUKA PHARMACEUTICAL CO., LTD.
18035134 COMPOSITIONS AND METHODS FOR SCREENING PESTICIDES Final Rejection Arizona Board of Regents on Behalf of the University of Arizona
18563088 ANTI-OXIDANT CONTAINING PARTICLES AND METHODS OF USE Non-Final OA The United States Government, as Represented by the Department of Veterans Affairs
18836135 USE OF PROBIOTICS FOR MODULATING ALLERGIC IMMUNE RESPONSES Non-Final OA INTERNATIONAL N&H DENMARK APS
18541764 DEVICES AND METHODS FOR DETECTING PANCREATIC LIPASE Final Rejection IDEXX LABORATORIES, INC.
18687533 ENZYME AGENT FOR TRANSESTERIFICATION, INCLUDING LIPASE AS ACTIVE INGREDIENT Non-Final OA AMANO ENZYME INC.
18254449 DESIGNED BACTERIAL COMPOSITIONS FOR TREATING GRAFT-VERSUS-HOST-DISEASE Non-Final OA Seres Therapeutics, Inc.
17767725 METHOD FOR PREVENTING HUMAN GLANDS FROM RADIATION DAMAGE Final Rejection MERZ THERAPEUTICS GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Ruth A Davis's allowance rate?

61.0% of resolved applications examined by Ruth A Davis were allowed (921 resolved cases), compared with 49.4% across Art Unit 1645 over the last five years.

Does an interview help with examiner Ruth A Davis?

This examiner's interview lift is +30.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Ruth A Davis take to allow a patent?

Applications allowed by Ruth A Davis took 1,168 days on average from filing to allowance.

Which art unit does examiner Ruth A Davis work in?

Ruth A Davis examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month